Alternatives to QuberTech

Cultivating wood directly into its final shape, 10,000x faster than forestry.

Turning CO2 into cellulose for textiles using an innovative, carbon-negative enzymatic process.

Developing high-performance, compostable foams from bacterial cellulose to replace fossil-based plastics.

Develops and commercializes biological solutions for pest control in plant, home, and public health sectors.

Developing circular biomass technology.

Developing a sustainable plastic alternative called Vivomer.

Industrial biotechnology company developing optogenetic control for industrial-scale precision fermentation.

Developing and industrializing cellulose-based superabsorbent materials as a fossil-free and biodegradable alternative.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Pioneering sustainable oils and fats through fermentation.

Developing disease-resistant crops using AI-driven platform to resurrect native resistance mechanisms.

Epoch Biodesign uses enzymes to break down plastic waste into monomers for new plastic production.

Pioneering Liquid State Intelligence for physical-world AI.

Developing biobased alternatives to conventional carbon-intensive construction binders.

Empowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.

Using microorganisms as programmable molecular factories for industrial ingredients.

Develops and deploys advanced biotechnology solutions for industrial resource challenges, focusing on wastewater treatment and energy recovery.

Notpla develops and produces sustainable, plastic-free packaging solutions from seaweed and plants, offering biodegradable and compostable alternatives for various applications.

Climate-tech startup making Asia's rice farming more water-resilient by combining satellite imagery, AI, and field operations to reduce water usage and methane emissions.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A biotechnology company focused on genetically engineered salmon for sustainable aquaculture.

AI-powered discovery and development of sustainable active ingredients for the Ag & Food industries.

Sustainable fats from carbon, revolutionizing food ingredients and personal care.

Gavan Technologies offers Fatrix, a next-generation fat system designed to provide indulgence without compromise in food products.

Sustainable insect farming solutions providing Black Soldier Fly eggs and neonates globally.

ClimateCrop uses gene discovery to enhance plant starch storage for increased yield and resilience.

Fueling a 21st-century renaissance by increasing the ambition of philanthropists, scientists, and innovators.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Turning low-grade plastic waste into building materials and home products.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Developing cellulose-based alternatives to titanium dioxide for cosmetics, food, and coatings.

Transforms organic byproducts into sustainable plant-based protein and prebiotic fiber ingredients.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing next-generation nanozyme catalysts to enable a more sustainable and efficient chemical production industry.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing novel therapeutics to restore gut lymphatic function.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Enzyme-based technology to break down alcohol in the stomach.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).